Inhibitory NKG2A
EBV - Epstein-Barr virus
EBV+ lymphoma
HLA-E polymorphism
LMP-1
NK cells
NKG2A
NKG2C NK cells
immune evasion
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
10
03
2023
accepted:
02
06
2023
medline:
11
7
2023
pubmed:
10
7
2023
entrez:
10
7
2023
Statut:
epublish
Résumé
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, which infects over 90% of the adult human population worldwide. After primary infections, EBV is recurrently reactivating in most adult individuals. It is, however, unclear, why these EBV reactivations progress to EBV
Identifiants
pubmed: 37426645
doi: 10.3389/fimmu.2023.1183788
pmc: PMC10324562
doi:
Substances chimiques
Peptides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1183788Informations de copyright
Copyright © 2023 Vietzen, Staber, Berger, Furlano, Kühner, Lubowitzki, Pichler, Strassl, Cornelissen and Puchhammer-Stöckl.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
PLoS One. 2015 Aug 11;10(8):e0135512
pubmed: 26261988
Nat Rev Microbiol. 2019 Nov;17(11):691-700
pubmed: 31477887
Front Oncol. 2022 Jan 11;11:797028
pubmed: 35087758
J Clin Virol. 2002 Jul;25 Suppl 1:S79-85
pubmed: 12091085
Tissue Antigens. 2009 Dec;74(6):514-9
pubmed: 19845911
Oncologist. 2011;16(1):87-96
pubmed: 21212426
J Immunother Cancer. 2019 Oct 17;7(1):263
pubmed: 31623687
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14725-32
pubmed: 21825173
Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732):
pubmed: 28893938
Blood. 2014 Oct 16;124(16):2533-43
pubmed: 25205117
PLoS Pathog. 2015 Dec 01;11(12):e1005286
pubmed: 26624012
Sci Rep. 2020 Nov 17;10(1):19973
pubmed: 33203899
Front Immunol. 2022 Mar 24;13:829228
pubmed: 35401541
Genet Med. 2021 May;23(5):963-967
pubmed: 33500568
Pathol Res Pract. 2012 Jan 15;208(1):45-9
pubmed: 22177730
Clin Cancer Res. 2019 Oct 15;25(20):6052-6060
pubmed: 31308062
Front Immunol. 2016 Dec 15;7:607
pubmed: 28018364
Blood Adv. 2021 Aug 24;5(16):3227-3239
pubmed: 34427583
J Cancer Res Clin Oncol. 2022 Jan;148(1):31-46
pubmed: 34705104
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Leukemia. 2016 Feb;30(2):456-63
pubmed: 26416461
Front Immunol. 2018 Feb 14;9:267
pubmed: 29491867
Cancers (Basel). 2020 Nov 18;12(11):
pubmed: 33218185
J Infect Dis. 2018 Feb 14;217(5):802-806
pubmed: 29220498
Blood. 2023 Mar 30;141(13):1560-1573
pubmed: 36477802
Front Immunol. 2017 Nov 24;8:1658
pubmed: 29225606
Front Immunol. 2018 Oct 17;9:2410
pubmed: 30386347
Blood Adv. 2022 Jan 11;6(1):28-36
pubmed: 34619756
J Clin Oncol. 2005 Oct 20;23(30):7604-13
pubmed: 16186595
J Immunol. 2013 Nov 15;191(10):4989-95
pubmed: 24108698